Clovis Oncology to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Webcast Conference Call on February 23
February 17 2021 - 8:00AM
Business Wire
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth
quarter and year-end 2020 financial results on Tuesday, February
23, 2021, before the open of the U.S. financial markets. Clovis’
senior management will host a conference call and live audio
webcast at 8:30 a.m. ET to discuss the Company’s results in greater
detail.
The conference call will be simultaneously webcast on the Clovis
Oncology website www.clovisoncology.com, and a replay of the
webcast will be available for 30 days.
Dial-in numbers for the conference call are as follows: US
participants (877) 698-7048, International participants (647)
689-5448, conference ID: 5869256.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners,
diagnostic tools intended to direct a compound in development to
the population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado; please visit
www.clovisoncology.com for more information, including additional
office locations in the U.S. and Europe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210217005190/en/
Clovis Investor Contacts: Anna Sussman 303.625.5022
asussman@clovisoncology.com
Breanna Burkart 303.625.5023 bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Apr 2023 to Apr 2024